Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11Obesity 4Sarcopenia 3Polycystic Ovary Syndrome 3Neoplasms 3Melanoma 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Malnutrition 2Lymphoma, Follicular 2Colorectal Neoplasms 2Breast Carcinoma In Situ 2Wound Infection 1Weight Loss 1Urinary Bladder Neoplasms 1Surgical Wound Infection 1Stomach Neoplasms 1Smoldering Multiple Myeloma 1Skin Neoplasms 1Psoriasis 1Precancerous Conditions 1Postoperative Complications 1Polyps 1Phagocyte Bactericidal Dysfunction 1Pain 1Paget's Disease, Mammary 1Overweight 1Osteoarthritis 1Olfaction Disorders 1Non-alcoholic Fatty Liver Disease 1

Interventions

Colonoscopy 7Endoscopy 3Narrow Band Imaging 2Eicosapentaenoic Acid 2eicosapentaenoic acid ethyl ester 1Uterine Myomectomy 1Ursodeoxycholic Acid 1Telemedicine 1Suppositories 1Sennosides 1Selenium 1Restraint, Physical 1Radiotherapy 1Propofol 1Polyethylene Glycols 1Ofloxacin 1Midazolam 1Metoclopramide 1Methods 1Folic Acid 1Fentanyl 1Fatty Acids, Omega-3 1Everolimus 1Erythromycin 1Endoscopic Mucosal Resection 1Endomet 1Doxycycline 1Docosahexaenoic Acids 1Diet, Fat-Restricted 1Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Polyps × Docosahexaenoic Acids × Clear all
NCT03806426 2024-04-25

Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

S.L.A. Pharma AG

Phase 3 Unknown
204 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡